Keyword search
Filter results by
Search HelpKeyword(s)
Type
Geography
Survey or statistical program
Results
All (13)
All (13) (0 to 10 of 13 results)
- Articles and reports: 75-006-X202300100015Description: This study uses data from the Canadian COVID-19 Antibody and Health Survey to describe the current COVID-19 landscape, including infection, reinfection, and acute and long-term symptoms. This study also examines how peoples’ experiences with the virus have evolved in the context of growing immunity, emerging variants, new treatments, and relaxation of public health measures.Release date: 2023-12-08
- Stats in brief: 11-001-X202334237707Description: Release published in The Daily – Statistics Canada’s official release bulletinRelease date: 2023-12-08
- Table: 13-10-0867-01Geography: CanadaFrequency: OccasionalDescription: Long term symptoms were defined as having COVID-19 symptoms at least 3 months after a self-reported positive test or suspected SARS-CoV-2 infection. Results on the status of long-term symptoms only included respondents for whom a period of three months separated their self-reported date of infection and the date they completed the questionnaire.Release date: 2023-08-03
- Table: 13-10-0868-01Geography: Canada, Geographical region of Canada, Province or territoryFrequency: OccasionalDescription: This survey provides new evidence about those who indicated on their electronic questionnaire a positive test result with either a positive polymerase chain reaction (PCR) test or a rapid antigen test (RAT), as well as those who suspected that they had an infection. These results are based on the individual's self-reported first positive test result or first suspected infection and does not account for multiple infections.Release date: 2023-08-03
- Public use microdata: 13-25-0009Description: This public use microdata file (PUMF) provides researchers access to data on the distribution of SARS-CoV-2 lineages detected in the Canadian provinces between May and September 2022. Samples were collected as part of the Canadian COVID-19 Antibody and Health Survey (CCAHS), Cycle 2. The PUMF file consists of a subset of participants of the CCAHS who submitted a positive PCR saliva sample over the course of the collection of the survey. The PUMF contains select demographic information including sex at birth, age group, province and the week of collection. The file also contains SARS-CoV-2 whole genome sequences and its associated data.Release date: 2023-05-25
- Table: 13-10-0866-01Geography: Canada, Geographical region of Canada, Province or territoryFrequency: OccasionalDescription: Dried blood spot testing was used to detect antibodies against SARS-CoV-2, the virus that causes COVID-19. The proportion of Canadians who have antibodies from infection is referred to as the seroprevalence of SARS-CoV-2.Release date: 2023-03-27
- Stats in brief: 11-001-X202234235645Description: Release published in The Daily – Statistics Canada’s official release bulletinRelease date: 2022-12-08
- Articles and reports: 82-003-X202201100003Description:
The Statistics Canada Biobank is a valuable source of nationally representative health information. It contains biospecimens collected from the Canadian Health Measures Survey (CHMS) and the Canadian COVID-19 Antibody and Health Survey (CCAHS). This data resource profile aims to provide an overview of the Statistics Canada Biobank to inform researchers and data users about the program and how it can be used as a resource for the advancement of health-related research.
Release date: 2022-11-16 - Public use microdata: 13-25-0007Description:
This public use microdata file (PUMF) contains data for a wide variety of variables collected from the Canadian COVID-19 Antibody and Health Survey (CCAHS). The CCAHS collected information on the presence of chronic conditions, self-reported COVID-19 status, testing history, risk for infection, health behaviours, vaccination status and intentions to get vaccinated. COVID-19 antibody seroprevalence laboratory data, and select demographic information are also available. Survey data were collected between November 2020 and April 2021, with the vast majority of collection occurring in January and February 2021.
Release date: 2022-11-16 - Articles and reports: 82-003-X202200900001Description:
Throughout the COVID-19 pandemic, Canadian public health officials have mandated and recommended precautions to slow the spread of COVID-19. This study examined which population groups were less compliant with precautions, such as mask-wearing and self-isolating, and where they were located in Canada.
Release date: 2022-09-15
Data (6)
Data (6) ((6 results))
- Table: 13-10-0867-01Geography: CanadaFrequency: OccasionalDescription: Long term symptoms were defined as having COVID-19 symptoms at least 3 months after a self-reported positive test or suspected SARS-CoV-2 infection. Results on the status of long-term symptoms only included respondents for whom a period of three months separated their self-reported date of infection and the date they completed the questionnaire.Release date: 2023-08-03
- Table: 13-10-0868-01Geography: Canada, Geographical region of Canada, Province or territoryFrequency: OccasionalDescription: This survey provides new evidence about those who indicated on their electronic questionnaire a positive test result with either a positive polymerase chain reaction (PCR) test or a rapid antigen test (RAT), as well as those who suspected that they had an infection. These results are based on the individual's self-reported first positive test result or first suspected infection and does not account for multiple infections.Release date: 2023-08-03
- Public use microdata: 13-25-0009Description: This public use microdata file (PUMF) provides researchers access to data on the distribution of SARS-CoV-2 lineages detected in the Canadian provinces between May and September 2022. Samples were collected as part of the Canadian COVID-19 Antibody and Health Survey (CCAHS), Cycle 2. The PUMF file consists of a subset of participants of the CCAHS who submitted a positive PCR saliva sample over the course of the collection of the survey. The PUMF contains select demographic information including sex at birth, age group, province and the week of collection. The file also contains SARS-CoV-2 whole genome sequences and its associated data.Release date: 2023-05-25
- Table: 13-10-0866-01Geography: Canada, Geographical region of Canada, Province or territoryFrequency: OccasionalDescription: Dried blood spot testing was used to detect antibodies against SARS-CoV-2, the virus that causes COVID-19. The proportion of Canadians who have antibodies from infection is referred to as the seroprevalence of SARS-CoV-2.Release date: 2023-03-27
- Public use microdata: 13-25-0007Description:
This public use microdata file (PUMF) contains data for a wide variety of variables collected from the Canadian COVID-19 Antibody and Health Survey (CCAHS). The CCAHS collected information on the presence of chronic conditions, self-reported COVID-19 status, testing history, risk for infection, health behaviours, vaccination status and intentions to get vaccinated. COVID-19 antibody seroprevalence laboratory data, and select demographic information are also available. Survey data were collected between November 2020 and April 2021, with the vast majority of collection occurring in January and February 2021.
Release date: 2022-11-16 - 6. SARS-CoV-2 antibody seroprevalence in Canadians, by age group and sex, November 2020 to April 2021Table: 13-10-0818-01Geography: Canada, Geographical region of Canada, Province or territoryFrequency: OccasionalDescription:
Seroprevalence of Canadians aged 1 and older with antibodies against SARS-CoV-2 (the virus that causes COVID-19), overall and by antibody type, by age group and sex.
Release date: 2021-07-06
Analysis (7)
Analysis (7) ((7 results))
- Articles and reports: 75-006-X202300100015Description: This study uses data from the Canadian COVID-19 Antibody and Health Survey to describe the current COVID-19 landscape, including infection, reinfection, and acute and long-term symptoms. This study also examines how peoples’ experiences with the virus have evolved in the context of growing immunity, emerging variants, new treatments, and relaxation of public health measures.Release date: 2023-12-08
- Stats in brief: 11-001-X202334237707Description: Release published in The Daily – Statistics Canada’s official release bulletinRelease date: 2023-12-08
- Stats in brief: 11-001-X202234235645Description: Release published in The Daily – Statistics Canada’s official release bulletinRelease date: 2022-12-08
- Articles and reports: 82-003-X202201100003Description:
The Statistics Canada Biobank is a valuable source of nationally representative health information. It contains biospecimens collected from the Canadian Health Measures Survey (CHMS) and the Canadian COVID-19 Antibody and Health Survey (CCAHS). This data resource profile aims to provide an overview of the Statistics Canada Biobank to inform researchers and data users about the program and how it can be used as a resource for the advancement of health-related research.
Release date: 2022-11-16 - Articles and reports: 82-003-X202200900001Description:
Throughout the COVID-19 pandemic, Canadian public health officials have mandated and recommended precautions to slow the spread of COVID-19. This study examined which population groups were less compliant with precautions, such as mask-wearing and self-isolating, and where they were located in Canada.
Release date: 2022-09-15 - Articles and reports: 82-003-X202200400003Description:
Certain population groups face a disproportionate burden of exposure to COVID-19. This study examined characteristics of Canadians living in private households in fall 2020 and winter 2021 who had been infected with COVID-19.
Release date: 2022-04-20 - Stats in brief: 11-001-X202118728984Description: Release published in The Daily – Statistics Canada’s official release bulletinRelease date: 2021-07-06
Reference (0)
Reference (0) (0 results)
No content available at this time.
- Date modified: